A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease.
Saved in:
| Title: | A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease. |
|---|---|
| Authors: | Feagan BG; The John P Robarts Research Institute, University of Western Ontario, London, ON, Canada. bfeagan@robarts.ca, Sandborn WJ, Baker JP, Cominelli F, Sutherland LR, Elson CO, Salzberg BA, Archambault A, Bernstein CN, Lichtenstein GR, Heath PK, Cameron S, Hanauer SB |
| Source: | Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2005 Feb 15; Vol. 21 (4), pp. 373-84. |
| Publication Type: | Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Print ISSN: 0269-2813 (Print) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 0269-2813 |
|---|---|
| DOI: | 10.1111/j.1365-2036.2005.02336.x |
